January 11th, Ukraine’s Lekhim Pharmaceutical Group signed a contract for the procurement of 5 million doses of coronavirus vaccine with China’s Kexing Company.
The group said that the Chinese vaccine provided an important guarantee for Ukraine to carry out mass vaccination in the first half of the year.
According to the contract, after the registration of the coronavirus vaccine produced by Kochen in Ukraine, Kochen will provide 5 million doses of coronavirus vaccine to Leckhim Pharmaceutical Group in the first half of this year.
Lexim Pharmaceutical Group stressed that 5 million doses of coronavirus vaccine are not the final procurement volume, and Uzbekistan will decide whether to increase the procurement of Kexing vaccine according to the development of the epidemic.
In addition, Lekhim also plans to start producing a number of Kochen vaccines, including the coronavirus vaccine, in Ukraine in 2022.